Year-end Sale % OFF 
Abstract
Background: The appropriate use of blood and blood components remains a formidable challenge faced by clinicians particularly in a developing country like India. The inadequate supply of safe blood implies that measures aimed at ensuring judicious use of the available supply should be continually identified and explored. Aims & Objectives: To study the indications and other factors related to component therapy. Materials and Methods: A retrospective study was conducted to evaluate all blood and blood component transfusions over a period of nine year, from 2003 to 2010. Results: A total of 100071 transfusion episodes were reviewed and analyzed. The commonest indication for use of blood/blood component was severe anaemia. Conclusion: Enhanced capacity for component preparation, regular auditing of transfusion practices as well as improved communication between the clinicians and laboratory physicians will lead to more judicious use of blood component therapy.
Submitted Version
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical Science and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
